The Valley Desk

NCT01492426 · Interventional trial

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

Overall registry status Completed

Phase 3

Conditions Hepatitis C

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov